Ogura Shokuhin Co Ltd FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Ogura Shokuhin Co Ltd has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Ogura Shokuhin Co Ltd, the most recent on May 1, 2024.

What these totals cover: FDA records filed under the name "Ogura Shokuhin Co Ltd" and its spelling variant "Ogura Shokuhin Co".

Latest inspection
Nov 17, 2009 · OAI

Reviewing Ogura Shokuhin Co Ltd as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ogura Shokuhin Co Ltd yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Ogura Shokuhin Co Ltd FDA Warning Letters

1 warning letter on May 1, 2024.

IssuedSubjectIssuing officeClose-out letter
May 1, 2024Seafood HACCP/CGMP for Foods/Adulterated/Insanitary ConditionsCenter for Food Safety and Applied Nutrition

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

1 inspection on Nov 17, 2009.

DateSiteProductClassificationFEI
Nov 17, 2009Shizuoka, JapanFood/CosmeticsOfficial Action Indicated (OAI)1000203650
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Ogura Shokuhin Co Ltd: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 6, 2024.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1000203650Shizuoka, Japan1Nov 17, 2009

Ogura Shokuhin Co Ltd and the FDA: common questions

Has Ogura Shokuhin Co Ltd received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Ogura Shokuhin Co Ltd. The most recent is dated May 1, 2024, with the subject "Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions".

Has Ogura Shokuhin Co Ltd received an FDA Form 483?

FDA has not published a Form 483 for "Ogura Shokuhin Co Ltd" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Ogura Shokuhin Co Ltd?

The most recent FDA inspection on file ended Nov 17, 2009 at Shizuoka, Japan and was classified OAI. FDA has 1 inspection of Ogura Shokuhin Co Ltd on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Ogura Shokuhin Co Ltd in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.